Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523962 · ClinicalTrials.gov registry record · Phase 4
Pre-operative Alcohol Skin Solutions in Fractured Extremities
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 8,485
- Enrollment target
NCT03523962 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 8,485 participants.
The verdict
NCT03523962, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8,485 participants
- Enrollment target
Study Summary
The prevention of infection is an important goal influencing peri-operative care of extremity fracture patients. Standard practice in the operative management of extremity fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kill bacteria and decrease the quantity of native skin flora, thereby decreasing surgical site infection (SSI). While there is extensive guidance on specific procedures for prophylactic antibiotic use and standards for sterile technique, the evidence regarding the choice of antiseptic skin preparation solution is very limited for extremity fracture surgery.
Interventions
- DRUG ChloraPrep
- DRUG DuraPrep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,485 participants |
| Start Date | 2018-08-21 |
| Est. Completion | 2024-02-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03523962
The ClinicalTrials.gov registry entry for NCT03523962 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8,485 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ChloraPrep is the first listed.
NCT03523962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03523962 about?
NCT03523962 is a clinical study titled "Pre-operative Alcohol Skin Solutions in Fractured Extremities". The prevention of infection is an important goal influencing peri-operative care of extremity fracture patients. Standard practice in the operative management of extremity fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kil...
What is the current status of trial NCT03523962?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8,485 participants. The study started on 2018-08-21. Estimated completion is 2024-02-02.
What interventions are being tested in trial NCT03523962?
The interventions under investigation include: ChloraPrep (DRUG), DuraPrep (DRUG).
Who is sponsoring clinical trial NCT03523962?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.